Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 650-654

  Zhang, Li Yong ^a   Ying, Wan Tao ^b   Mao, You Sheng ^a   He, Hong Zhi ^a   Liu, Yu ^a   Wang, Hui Xin ^a   Liu, Fang ^a   Wang, Kun ^c   Zhang, De Chao ^a   Wang, Ying ^a   Wu, Min ^a   Qian, Xiao Hong ^b   Zhao, Xiao Hang ^a  

^a CANCER HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c Yanjing Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DENSITY; DOWN REGULATION; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DATABASE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SILVER STAINING; SQUAMOUS CELL CARCINOMA; TISSUE LEVEL; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 0037963140     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.650     Document Type: Article

References (33)

1. Zhang WH, Bailey-Wilson JE, Li WD, Wang XQ, Zhang CL, Mao XZ, Liu ZH, Zhou CN, Wu M. Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet 2000; 67: 110-119
2. Wang DX, Li W. Advances on pathogenesis of esophageal cancer. Shijie Huaren Xiaohua Zazhi 2000; 8: 1029-1030
3. Hu SP, Yang HS, Shen ZY. Study on etiology of esophageal carcinoma: Retrospect and prospect. Zhongguo Aizheng Zazhi 2001; 11: 171-174
4. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, Hazama S, Hirazawa K, Hayashi H, Tangoku A, Hirose K, Ishihara T, Suzuki T. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 1996; 56: 2776-2780
5. Lu J, Liu Z, Xiong M, Wang Q, Wang X, Yang G, Zhao L, Qiu Z, Zhou C, Wu M. Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001; 91: 288-294
6. Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF III. Loss of annexin I correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000; 60: 6293-6297
7. Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR, Emmert-Buck MR, Liotta LA, Petricoin EF III, Zhao Y. 2D differential in-gel electrophoresis for the identification of esophageal of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 2002; 1: 117-124
8. Xiong XD, Xu LY, Shen ZY, Cai WJ, Luo JM, Han YL, Li EM. Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry. World J Gastroenterol 2002; 8: 777-781
9. Li F, Guan YJ, Chen ZC. Proteomics in cancer research. Shengwu Huaxue Yu Shengwu Wuli Jinzhan 2001; 28: 164-167
10. Wang H, Hanash SM. Contributions of proteome profiling to the molecular analysis of cancer. Technology in Cancer Research & Treatment 2002; 1: 1-8
11. Vercoutter-Edouart AS, Lemoine J, Louis H, Boilly B, Nurcombe V, Revillion F, Peyrat JP, Hondermarck H. Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells. Cancer Res 2001; 61: 76-80
12. Zhan XQ, Chen ZC, Guan YJ, Li C, He CM, Liang SP, Xie JY, Chen P. Analysis of human lung squamous carcinoma cell line NCI-H520 proteome by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry. Ai Zheng 2001; 20: 575-582
13. Parczyk K, Pilarsky C, Rachel U, Koch-Brandt C. Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J Cancer Res Clin Oncol 1994; 120: 186-188
14. Trougakos IP, Gonos ES. Clusterin/Apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 2002; 34: 1430-1448
15. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002; 34: 427-431
16. Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 2000; 97: 5907-5912
17. Redondo M, Villar E, Torres-Munoz J, Tellez T, Morell M, Petito CK. Overexpression of clusterin in human breast carcinoma. Am J Pathol 2000; 157: 393-399
18. Behrens P, Jeske W, Wernert N, Wellmann A. Downregulation of clusterin expression in testicular germ cell tumours. Pathobiology 2001; 69: 19-23
19. Tobe T, Minoshima S, Yamase S, Choi NH, Tomita M, Shimizu N. Assignment of a human serum glycoprotein SP-40, 40 gene (CLI) to chromosome 8. Cytogenet Cell Genet 1991; 57: 193-195
20. Wellmann A, Thieblement C, Pittaluga S, Sakai A, Jaffe ES, Siebert P, Raffeld M. Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of as a new diagnostic marker for anaplastic large-cell lymphomas. Blood 2000; 91: 398-404
21. Hasan Q, Ruger BM, Tan ST, Gush J, Davis PF. Clusterin/ apo J expression during the development of hemangioma. Hum Pathol 2000; 31: 691-697
22. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ. Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001; 61: 3869-3876
23. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 1992; 11: 197-220
24. Kadomatsu K, Anzano MA, Slayter MV, Winokur TS, Smith JM, Sporn MB. Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res 1993; 53: 1480-1483
25. Miyake H, Gleave ME, Arakawa S, Kamidono S, Hara I. Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential. J Urol 2002; 167: 2203-2208
26. Hara I, Miyake H, Gleave ME, Kamidono S. Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo. Jpn J Cancer Res 2001; 92: 1220-1224
27. Welsh J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 1994; 72: 537-545
28. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, Tschopp J, French LE. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 1999; 112: 290-296
29. Zellweger T, Miyake H, Cooper S, Chi K, Conklin BS, Monia BP, Gleave ME. Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp Ther 2001; 298: 934-940
30. Yamori T, Kimura H, Stewart K, Ota DM, Cleary KR, Irimura T. Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma and metastasis. Cancer Res 1987; 47: 2741-2747
31. Longo VD, Viola KL, Klein WL, Finch CE. Reversible inactivation of superoxide-sensitive aconitase in Abeta1-42-treated neuronal cell lines. J Neurochem 2000; 75: 1977-1985
32. Zellweger T, Chi K, Miyake H, Adomat H, Kiyama S, Skov K, Gleave ME. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin. Clin Cancer Res 2002; 8: 3276-3284
33. Morrissey C, Lakins J, Moquin A, Hussain M, Tenniswood M. An antigen capture assay for the measurement of serum clusterin concentrations. J Biochem Biophy Methods 2001; 48: 13-21